(0.00%) 5 187.67 points
(0.44%) 39 056 points
(-0.18%) 16 303 points
(0.39%) $79.30
(-0.46%) $2.18
(-0.23%) $2 317.00
(-0.09%) $27.58
(0.30%) $987.60
(0.06%) $0.931
(0.15%) $10.91
(0.03%) $0.800
(0.01%) $91.75
Quarter results today
(bmo 2024-05-09)
Expected move: +/- 9.89%
-0.94% $ 0.307
Live Chart Being Loaded With Signals
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States...
Stats | |
---|---|
Dzisiejszy wolumen | 218 115 |
Średni wolumen | 679 885 |
Kapitalizacja rynkowa | 30.89M |
EPS | $0 ( 2024-03-28 ) |
Następna data zysków | ( $-0.0600 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.880 |
ATR14 | $0.00100 (0.32%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-12 | Fair John A | Buy | 290 000 | Employee Stock Option (right to buy) |
2024-03-12 | Johnson Sabrina Martucci | Buy | 750 000 | Employee Stock Option (right to buy) |
2024-03-12 | Haring-layton Mardee | Buy | 290 000 | Employee Stock Option (right to buy) |
2024-01-26 | Haring-layton Mardee | Sell | 3 500 | Employee Stock Option (right to buy) |
2024-01-26 | Haring-layton Mardee | Sell | 30 000 | Employee Stock Option (right to buy) |
INSIDER POWER |
---|
78.57 |
Last 91 transactions |
Buy: 10 072 923 | Sell: 492 500 |
Wolumen Korelacja
Dare Bioscience Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
PRPO | 0.884 |
BCDA | 0.881 |
UCL | 0.875 |
SNDL | 0.872 |
AQB | 0.872 |
JOAN | 0.87 |
POTX | 0.87 |
AQMS | 0.87 |
STAF | 0.87 |
BLNK | 0.868 |
10 Najbardziej negatywne korelacje | |
---|---|
LEDS | -0.902 |
MPRA | -0.871 |
MTEK | -0.865 |
OBNK | -0.861 |
PUCKU | -0.841 |
MTEM | -0.838 |
BWMX | -0.836 |
NCAC | -0.834 |
MTCR | -0.832 |
CCRC | -0.83 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Dare Bioscience Inc Korelacja - Waluta/Towar
Dare Bioscience Inc Finanse
Annual | 2023 |
Przychody: | $2.81M |
Zysk brutto: | $2.77M (98.63 %) |
EPS: | $-0.350 |
FY | 2023 |
Przychody: | $2.81M |
Zysk brutto: | $2.77M (98.63 %) |
EPS: | $-0.350 |
FY | 2022 |
Przychody: | $10.00M |
Zysk brutto: | $9.95M (99.52 %) |
EPS: | $4.81 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.630 |
Financial Reports:
No articles found.
Dare Bioscience Inc
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in female patients 12 years of age and older. Its products in advanced clinical development include Ovaprene, a hormone-free monthly vaginal contraceptive; and Sildenafil Cream, a cream formulation of sildenafil for topical administration to the vulva and vagina for treatment of female sexual arousal disorder. The company's Phase 1-ready products are DARE-HRT1, a combination of bio-identical estradiol and progesterone intravaginal ring for the treatment of vasomotor symptoms in hormone therapy; DARE-VVA1, a vaginally delivered formulation of tamoxifen to treat vulvar and vaginal atrophy in patients with hormone-receptor positive breast cancer; and DARE-FRT1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth and broader luteal phase support as part of an in vitro fertilization treatment plan, as well as DARE-PTB1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth. Its products in pre-clinical stage include DARE-LARC1, a combination product designed to provide reversible contraception; ADARE-204 and ADARE-214, an injectable formulations of etonogestrel to provide contraception over 6-month and 12-month periods; and DARE-RH1, a non-hormonal contraception for men and women. The company entered into license agreement with Organon & Co. and Organon International GmbH to commercialize XACIATO. Daré Bioscience, Inc. is headquartered in San Diego, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej